Thanks for the insight BDAZ.

I guess for me, not being a scientist but intensely interested in science, the perspectives provided by you and other science posters as well as all of the posts, news releases by Resverlogix and all of the discoveries in the post hoc analysis I remain long on the stock.

I appreciate the reinforcement or perhaps repetition of valuable information such as "the article that you posted on HDL efflux capacity being correlated with CAD even moreso that HDL levels is spot on. It's not just HDL levels....its HDL functionality. This has been the bread and butter of RVX-208 all along. Unlike CETP inhibitors, which may raise HDL levels but at the cost of decreased HDL functionality, RVX-208 gives rise to more functional HDL."